Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chairman and CEO

Chairman, President & CEO

SVP of Finance, CFO

EVP, Chief Commercial Officer

EVP and General Counsel

EVP, Chief Medical Officer

Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing Lumateperone, which is in Phase 3 clinical trial for the treatment of various depressive disorders, as well as additional neuropsychiatric indications. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease, heart failure, CNS, and other disorders; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression, anxiety, and sleep disorders. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of smal...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-24	Premium	acquired	Premium	Premium	Premium	Chairman and CEO
2024-03-31	Premium	acquired	Premium	Premium	Premium	-
2024-03-31	Premium	acquired	Premium	Premium	Premium	-
2024-03-20	Premium	acquired	Premium	Premium	Premium	-
2024-03-11	Premium	sold	Premium	Premium	Premium	Chairman, President & CEO
2024-03-11	Premium	sold	Premium	Premium	Premium	SVP of Finance, CFO
2024-03-11	Premium	sold	Premium	Premium	Premium	EVP, Chief Commercial Officer
2024-03-11	Premium	sold	Premium	Premium	Premium	EVP and General Counsel
2024-03-11	Premium	sold	Premium	Premium	Premium	EVP, Chief Medical Officer
2024-03-10	Premium	acquired	Premium	Premium	Premium	EVP and General Counsel
2024-03-10	Premium	acquired	Premium	Premium	Premium	EVP, Chief Medical Officer
2024-03-10	Premium	acquired	Premium	Premium	Premium	Chairman, President & CEO
2024-03-10	Premium	acquired	Premium	Premium	Premium	SVP of Finance, CFO
2024-03-10	Premium	acquired	Premium	Premium	Premium	EVP, Chief Commercial Officer
2024-03-07	Premium	sold	Premium	Premium	Premium	SVP of Finance, CFO
2024-03-07	Premium	sold	Premium	Premium	Premium	Chairman, President & CEO
2024-03-07	Premium	sold	Premium	Premium	Premium	EVP, Chief Commercial Officer
2024-03-07	Premium	sold	Premium	Premium	Premium	EVP, Chief Medical Officer
2024-03-07	Premium	sold	Premium	Premium	Premium	EVP and General Counsel
2024-03-06	Premium	acquired	Premium	Premium	Premium	EVP and General Counsel
2024-03-06	Premium	acquired	Premium	Premium	Premium	Chairman, President & CEO
2024-03-06	Premium	acquired	Premium	Premium	Premium	SVP of Finance, CFO
2024-03-06	Premium	acquired	Premium	Premium	Premium	EVP, Chief Medical Officer
2024-03-06	Premium	acquired	Premium	Premium	Premium	EVP, Chief Commercial Officer
2024-02-27	Premium	sold	Premium	Premium	Premium	-

ITCI - Intra-Cellular Therapies Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ITCI